Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions

Thevis M, Thomas A, Schänzer W. Expert Review of Proteomics 2019

Document identifier
CEI-BR-108
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Thevis M, Thomas A, Schänzer W
Title
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions
Source
Expert Review of Proteomics
Year
2019
Volume, issue, pages
11(6):663–673
Digital object identifier
10.1586/14789450.2014.965158
PubMed identifier
not held by the Institute
Record type
Journal article
Institute identifier
CEI-BR-108

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

§1.3Subject tags

analytical peptide doping

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.